Exos Asset Management LLC Humacyte, Inc. Transaction History

Exos Asset Management LLC

  • $1.03 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$3.21 - $7.86 $4,895 - $11,986
-1,525 Reduced 8.19%
17,084 $55,000
Q1 2022

Apr 13, 2022
BUY
$4.65 - $7.4 $11,485 - $18,278
2,470 Added 15.3%
18,609 $131,000
Q4 2021

Mar 14, 2022
SELL
$7.25 - $11.6 $20,321 - $32,514
-2,803 Reduced 14.8%
16,139 $117,000
Q3 2021

Oct 25, 2021
BUY
$9.21 - $16.99 $174,455 - $321,824
18,942 New
18,942 $220,000

Others Institutions Holding HUMA

# of Institutions
150
Shares Held
35.1M
Call Options Held
279K
Put Options Held
607K
View Full List

About Humacyte, Inc.

HUMA Quotes by TradingView
  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $478M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Exos Asset Management LLC Portfolio

Follow Exos Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exos Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exos Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email